Bacaan lanjut Vaksin ebola

Farooq F, Beck K, Paolino KM, Phillips R, Waters NC, Regules JA, Bergmann-Leitner ES (June 2016). "Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine". Scientific Reports. 6: 27944. Bibcode:2016NatSR...627944F. doi:10.1038/srep27944. PMC 4914957. PMID 27323685.
Sullivan N, Yang ZY, Nabel GJ (September 2003). "Ebola virus pathogenesis: implications for vaccines and therapies". Journal of Virology. 77 (18): 9733–7. doi:10.1128/JVI.77.18.9733-9737.2003. PMC 224575. PMID 12941881.
Diakite I, Mooring EQ, Velásquez GE, Murray MB (August 2016). "Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model". PLOS Neglected Tropical Diseases. 10 (8): e0004866. doi:10.1371/journal.pntd.0004866. PMC 4979980. PMID 27509037.
Cazares LH, Ward MD, Brueggemann EE, Kenny T, Demond P, Mahone CR, dll. (5 September 2016). "Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations". Clinical Proteomics. 13 (1): 18. doi:10.1186/s12014-016-9119-8. PMC 5011338. PMID 27597813.
Konduru K, Shurtleff AC, Bradfute SB, Nakamura S, Bavari S, Kaplan G (13 September 2016). "Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge". PLOS ONE. 11 (9): e0162446. Bibcode:2016PLoSO..1162446K. doi:10.1371/journal.pone.0162446. PMC 5021345. PMID 27622456.
Cheng F, Murray JL, Zhao J, Sheng J, Zhao Z, Rubin DH (September 2016). "Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis". PLOS Computational Biology. 12 (9): e1005074. Bibcode:2016PLSCB..12E5074C. doi:10.1371/journal.pcbi.1005074. PMC 5025164. PMID 27632082.
Olowookere SA, Abioye-Kuteyi EA, Adekanle O (November 2016). "Willingness to participate in Ebola viral disease vaccine trials and receive vaccination by health workers in a tertiary hospital in Ile-Ife, Southwest Nigeria". Vaccine. 34 (47): 5758–5761. doi:10.1016/j.vaccine.2016.10.004. PMID 27751640.
Pavot V (December 2016). "Ebola virus vaccines: Where do we stand?". Clinical Immunology. 173: 44–49. doi:10.1016/j.clim.2016.10.016. PMID 27910805.
The Wellcome Trust–CIDRAP Ebola Vaccine Team B (January 2017). Completing the development of Ebola vaccines: current status, remaining challenges, and recommendations. Center for Infectious Disease Research and Policy (CIDRAP) and Wellcome Trust. Diarkibkan (PDF) from yang asal pada 18 January 2017. Dicapai pada 18 January 2017.
Rosales-Mendoza S, Nieto-Gómez R, Angulo C (1 January 2017). "A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus". Frontiers in Immunology. 8: 252. doi:10.3389/fimmu.2017.00252. PMC 5344899. PMID 28344580.

Rencana berkenaan perubatan ini ialah rencana tunas. Anda boleh membantu Wikipedia dengan mengembangkannya.

Berkaitan

Vaksin Vaksin COVID-19 Vaksin COVID-19 Oxford–AstraZeneca Vaksin COVID-19 Pfizer–BioNTech Vaksin malaria Vaksin tetanus Vaksin difteria Vaksin virus papiloma manusia (HPV) Vaksin campak Vaksin rubela

Rujukan

WikiPedia: Vaksin ebola http://www.pharmatimes.com/news/us_approves_mercks... http://www.cidrap.umn.edu/completing-development-e... //pubmed.ncbi.nlm.nih.gov/12941881 //pubmed.ncbi.nlm.nih.gov/26249231 //pubmed.ncbi.nlm.nih.gov/27323685 //pubmed.ncbi.nlm.nih.gov/27496978 //pubmed.ncbi.nlm.nih.gov/27509037 //pubmed.ncbi.nlm.nih.gov/27597813 //pubmed.ncbi.nlm.nih.gov/27622456 //pubmed.ncbi.nlm.nih.gov/27632082